Kestra Medical Technologies (KMTS) Cash & Current Investments (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Cash & Current Investments for 3 consecutive years, with $358.9 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Current Investments rose 51.07% year-over-year to $358.9 million; the TTM figure through Apr 2026 stood at $358.9 million (up 51.07% YoY), while the FY2026 annual figure was $358.9 million, up 51.07% from the prior year.
• Cash & Current Investments climbed to $358.9 million in Q2 2026 per KMTS's latest filing, from $291.3 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $358.9 million in Q2 2026 and bottomed at $8.2 million in Q2 2024.
• Historically, Cash & Current Investments has averaged $151.9 million across 3 years, with a median of $137.7 million in 2024.
• Annual changes were most pronounced in 2025 — Cash & Current Investments jumped 2780.29% — and 2026, when it soared 51.07%.
• Kestra Medical Technologies' Cash & Current Investments stood at $76.9 million in 2024, then soared by 128.07% to $175.4 million in 2025, then jumped by 104.6% to $358.9 million in 2026.
• Business Quant data shows KMTS's Cash & Current Investments at $358.9 million in Q2 2026, $291.3 million in Q1 2026, and $175.4 million in Q4 2025.